Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study
Journal of Atherosclerosis and Thrombosis · 01.02.2025 · 32 (2) · 210-225
DOI: 10.5551/jat.64887 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.02.2025. Verfasst von Shun Ishibashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University. Hauptthemen laut MEDLINE: Benzoxazoles, Butyrates, Dyslipidemias, Renal Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University.
- Ishibashi Diabetes and Endocrine Clinic.
- National Center for Geriatrics and Gerontology.
- Chiba University.
- Kikuchi Medical Association Hospital.
- Research Center for Health and Sports Sciences, Kumamoto Health Science University.
Zitieren
APA
Ishibashi, S., Arai, H., Yokote, K., Araki, E., Watanabe, M., Nakanishi, M., Makinose, Y., Suganami, H., Kurihara, Y., & Yamashita, S. (2025). Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study. Journal of Atherosclerosis and Thrombosis, 32(2), 210-225. https://doi.org/10.5551/jat.64887
Vancouver
Ishibashi S, Arai H, Yokote K, Araki E, Watanabe M, Nakanishi M, et al. Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study. Journal of Atherosclerosis and Thrombosis. 2025;32(2):210-225. doi:10.5551/jat.64887
BibTeX
@article{Ishibashi2025,
author = {Ishibashi, Shun and Arai, Hidenori and Yokote, Koutaro and Araki, Eiichi and Watanabe, Mao and Nakanishi, Michiko and Makinose, Yuichi and Suganami, Hideki and Kurihara, Yuji and Yamashita, Shizuya},
title = {Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2025},
volume = {32},
number = {2},
pages = {210--225},
doi = {10.5551/jat.64887}
}
EUVIMED